tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market
PRAX
Praxis Precision Medicines
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Praxis Precision Medicines (PRAX) Stock News & Sentiment

Compare
579 Followers
Buy Recommendation for Ulixacaltamide Stock Amid Phase 3 Study Scenarios
Premium
Ratings
Buy Recommendation for Ulixacaltamide Stock Amid Phase 3 Study Scenarios
12d ago
PRAX
GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth
Premium
Market News
GeneDx (WGS), An Emerging Powerhouse in Genomics Sees Explosive Growth
2M ago
WGS
BIIB
Praxis Precision Medicines Reports Q3 2024 Results and Progress
Premium
Company Announcements
Praxis Precision Medicines Reports Q3 2024 Results and Progress
4M ago
PRAX
Praxis Precision Advances CNS Disorder Therapies
Premium
Company Announcements
Praxis Precision Advances CNS Disorder Therapies
4M ago
8K
PRAX
Praxis Precision Updates Executive Severance Packages
Premium
Company Announcements
Praxis Precision Updates Executive Severance Packages
4M ago
8K
PRAX
Praxis Precision Medicines’ Promising EMBOLD Study Outcomes
Premium
Company Announcements
Praxis Precision Medicines’ Promising EMBOLD Study Outcomes
6M ago
8K
PRAX
Praxis Precision Medicines Unveils Updated Corporate Presentation
Premium
Company Announcements
Praxis Precision Medicines Unveils Updated Corporate Presentation
6M ago
8K
PRAX
More PRAX News >

PRAX News on the Web

Steven Cohen's Strategic Acquisition in Praxis Precision Medicines Inc
GuruFocus News
Neutral
Ensign Group (ENSG) Q4 Earnings and Revenues Beat Estimates
Zacks
Neutral
Praxis Precision Medicines to Present at Two February Investor Conferences
Yahoo Finance
Neutral
Noteworthy Friday Option Activity: HOG, PRAX, QCOM
BNK Invest
Neutral
Piper Sandler Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)
TipRanks News
Bullish
Praxis Precision Medicines Inc (PRAX) Announces Significant Progress in CNS Disorder Therapies
GuruFocus News
Neutral
Capricor, Gilead, Kymera, Praxis among Oppenheimer's top biotech picks for 2025
The Fly
Neutral
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates
Zacks
Neutral

News Score - Last 7 Days

Neutral
PRAX
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRAX’s Media Buzz Sentiment?
Currently, no data Available
What is PRAX’s weekly average amount of articles?
Currently, no data Available
What is PRAX’s News Sentiment?
50% of articles about PRAX were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    SHGSingular Health Group Ltd
    RCUSArcus Biosciences
    HCMHUTCHMED
    PENPenumbra
    AMNAMN Healthcare Services
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing